Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 145

Sort by

Sort Order Select

Journal Articles

Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders

Blood (2019) 134 (23): 2082–2091.

https://doi.org/10.1182/blood.2018891192

Published: 2019

Includes: Supplemental data

Journal Articles

Immunological Consequences of Lenalidomide with and without Dexamethasone in Newly Diagnosed Multiple Myeloma

Jake A. Kloeber, Teresa K. Kimlinger, Jessica L. Haug, Kimberly J. Henderson, S.Vincent Rajkumar, MD, Shaji K. Kumar, MD

Blood (2019) 134 (Supplement_1): 3070.

https://doi.org/10.1182/blood-2019-128335

Published: 2019

Journal Articles

A Discrete Event Simulation Model to Evaluate the Impact of Treatment Sequences on Long-Term Patient Outcomes in Multiple Myeloma (MM)

Jinan Liu, PhD, Daniel Moldaver, PhD, Xinmei Zhu, PhD, Allen Zhou, BASc, Eric M Maiese, PhD, Sarah Hollmann, M.Biotech

Blood (2019) 134 (Supplement_1): 4737.

https://doi.org/10.1182/blood-2019-123804

Published: 2019

Journal Articles

Patient Experience of Chimeric Antigen Receptor (CAR)-T Cell Therapy Vs. Stem Cell Transplant: Longitudinal Patient Reported Adverse Events, Cognition and Quality of Life

Surbhi Sidana, MD, Gita Thanarajasingam, MD, Joan Griffin, PhD, Carrie A. Thompson, MD, Michelle Burtis, Rahma Warsame, MD, Jonas Paludo, MD, Andrea Cheville, Morie A Gertz, MD, Angela Dispenzieri, MD, Jose Villasboas, MD, Stephen M Ansell, MD PhD, S. Vincent Rajkumar, MD, Kathleen J Yost, PhD, N. Nora Bennani, MD, Mustaqeem Siddiqui, MD, Yi Lin, MD PhD, Shaji K. Kumar, MD, Amylou C. Dueck, PhD

Blood (2019) 134 (Supplement_1): 794.

https://doi.org/10.1182/blood-2019-121715

Published: 2019

Journal Articles

RNA Splicing Defects in Cancer-Linked Genes Indicate Mutation or Focal Gene Deletion and Are Associated with TKI Resistance in CML

Naranie Shanmuganathan, MBBS FRACP FRCPA, Daniel Thomson, PhD BSc, Carol Wadham, PhD, Verity A Saunders, Nur Hezrin Shahrin, PhD, David T Yeung, PhDBSc,FRACP,FRCPA,MBBS, Hamish S Scott, PhD FFSc (RCPA), Timothy P. Hughes, MDMBBS,FRACP,FRCPA, Andreas Schreiber, Susan Branford, PhD FFSc (RCPA)

Blood (2019) 134 (Supplement_1): 662.

https://doi.org/10.1182/blood-2019-123180

Published: 2019

Journal Articles

The SF3b Splicing Complex Regulates DNA Damage Response in Acute Lymphoblastic Leukemia

Shalini Sankar, Miriam Guillen Navarro, Frida Ponthan, PhD, Simon Bomken, MD, Sirintra Nakjang, Vasily Grinev, PhD, Hesta McNeill, Michel C Zwaan, MD PhD, Josef Vormoor, MD PhD, Ronald W. Stam, PhD, Olaf Heidenreich

Blood (2019) 134 (Supplement_1): 1237.

https://doi.org/10.1182/blood-2019-124787

Published: 2019

Journal Articles

Efficacy of Fecal Microbiota Transplant in Hematological Cancers Patients with Recurrent Clostridioides Difficile Infection: A Systemic Review and Meta-Analysis

Raseen Tariq, MBBS, Fateeha Furqan, MD, Saad Jamshed, MD, Sahil Khanna, MBBS

Blood (2019) 134 (Supplement_1): 5870.

https://doi.org/10.1182/blood-2019-131431

Published: 2019

Journal Articles

Cost-Utility Analysis of Apixaban Compared to Usual Care for the Primary Thromboprophylaxis of Ambulatory Cancer Patients Initiating Chemotherapy

Miriam Kimpton, MD, Srishti Kumar, MSc, Philip S. Wells, MDMSc,FRCP, Marc Carrier, MD, Kednapa Thavorn, MPharm, PhD

Blood (2019) 134 (Supplement_1): 329.

https://doi.org/10.1182/blood-2019-127286

Published: 2019

Journal Articles

Safety and Antithrombotic Efficacy of the Recombinant Protein C Activator AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis

Norah G Verbout, PhD, Christina U Lorentz, PhD, Brandon D Markway, PhD, Joseph J Shatzel, MD, Erik I Tucker, PhD, Andras Gruber, MD

Blood (2019) 134 (Supplement_1): 2433.

https://doi.org/10.1182/blood-2019-124999

Published: 2019

Journal Articles

Population Pharmacokinetic Analysis of the MDM2 Inhibitor KRT-232 (formerly AMG 232) in Subjects with Advanced Solid Tumors, Multiple Myeloma or Acute Myeloid Leukemia

Shu Chin Ma, PhD, Russ Wada, PhD, Martine Allard, PhD, Greg Slatter, PhD

Blood (2019) 134 (Supplement_1): 5766.

https://doi.org/10.1182/blood-2019-131331

Published: 2019

Journal Articles

Meta-Analyses of Clinical Trials Comparing the Progression Free Survival and Adverse Events in Treated Versus Observed Patients with Smoldering and Indolent Multiple Myeloma

Fahrettin Covut, MD, Tariq Zuheir Kewan, MD, Apoorva Anandan, MD, Folashade Otegbeye, MBBChir,MPH, James Driscoll, MD PhD, Marcos de Lima, MD, Ehsan Malek, MD

Blood (2019) 134 (Supplement_1): 2196.

https://doi.org/10.1182/blood-2019-125954

Published: 2019

Journal Articles

Poisson Regression Modeling of Chronic Myeloid Leukemia Mortality Trends

Tomas Radivoyevitch, Brian P. Hobbs, PhD, Jaroslaw P. Maciejewski

Blood (2018) 132 (Supplement 1): 4274.

https://doi.org/10.1182/blood-2018-99-118143

Published: 2018

Journal Articles

Transcriptional and Functional Description of Stem Cell Heterogeneity in Native and Transplantation Hematopoiesis

Alejo E Rodriguez-Fraticelli, PhD, Caleb Weinreb, Allon Moshe Klein, Fernando Camargo, PhD

Blood (2018) 132 (Supplement 1): 3844.

https://doi.org/10.1182/blood-2018-99-113646

Published: 2018

Journal Articles

Investigation of the Significance of Son Isoform mRNA Expression in Patients with Blood Cytopenias with/without Evidence of Myeloid Neoplasia

Jung-Hyun Kim, PhD, Eun-Young Erin Ahn, PhD, Aliyeh Kennedy, Aaron Dinerman, Thomas W Butler, MD

Blood (2018) 132 (Supplement 1): 5123.

https://doi.org/10.1182/blood-2018-99-120211

Published: 2018

Journal Articles

Aspartate Beta-Hydroxylase (ASPH) As a Novel Therapeutic Target in Acute Myeloid Leukemia

Noa G. Holtzman, MD, Michael S. Lebowitz, PhD, Rima Koka, MD PhD, Maria R. Baer, MD, Kanam Malhotra, Steven A. Fuller, PhD, Amir Shahlaee, MD, Hossein A. Ghanbari, PhD, Soren M. Bentzen, PhD DMSc, Ashkan Emadi, MD PhD

Blood (2018) 132 (Supplement 1): 5273.

https://doi.org/10.1182/blood-2018-99-110897

Published: 2018

Journal Articles

Whole Genome Sequencing in Routine Hematologic Samples: How to Proceed Analyses Best When Germline Controls Are Missing?

Stephan Hutter, PhD, Niroshan Nadarajah, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2018) 132 (Supplement 1): 5275.

https://doi.org/10.1182/blood-2018-99-113294

Published: 2018

Journal Articles

Single Cell RNA Sequencing of Blood Outgrowth Endothelial Cells from Patients with Low Von Willebrand Factor Reveal Multiple Novel Signaling Pathways

Christopher J. Ng, MD, Alice Liu, BS, Katrina J. Ashworth, MS, Kenneth L. Jones, PhD, Jorge Di Paola, MD

Blood (2018) 132 (Supplement 1): 982.

https://doi.org/10.1182/blood-2018-99-116694

Published: 2018

Journal Articles

18 f-Fludeoxyglucose and 11 c-Methionine PET/CT Scans in Patients with Multiple Myeloma Following Autologous Stem-Cell Transplantation (auto-HSCT)

Maxim V. Solovev, MD, Larisa P. Mendeleeva, MD PhD Prof, Maiia V. Firsova, MD PhD, Irakly P. Aslanidi, Olga V. Mukhortova, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 3433.

https://doi.org/10.1182/blood-2018-99-112886

Published: 2018

Journal Articles

Whole-Genome Genomics Correlates of Response to Anti-PD1 Therapy in Relapsed/Refractory Natural Killer/T Cell Lymphoma

Jing Quan Lim, PhD, Tiffany Tang, MBBS, MRCP, Daryl Tan, MD, Yurike Laurensia, Burton Chia Kuan Hui, Bsc, Jabed Iqbal, MD, Dachuan Huang, PhD, Tammy Song, PhD, Cedric Chuan Young Ng, MSc, Huangming Hong, Rex Au-Yeung, Benjamin Mow, MD, Qichun Cai, MD, LM Poon, Yok-Lam Kwong, Jin-Xin BEI, PhD, Tongyu Lin, Soon Thye Lim, Choon Kiat Ong, PhD

Blood (2018) 132 (Supplement 1): 2915.

https://doi.org/10.1182/blood-2018-99-110900

Published: 2018

Journal Articles

Cell-Free DNA Analysis Demonstrates Comprehensive Genomic Profiling and a Facile Method to Sensitively in Multiple Myeloma

Juan Du, MD PhD, Jing Lu, Wanting Qiang, Lu Li, Jin Liu, Hua Jiang, MD, Ziliang Qian, PhD, Baoan Chen, MD PhD, Weijun Fu, MD PhD

Blood (2018) 132 (Supplement 1): 5603.

https://doi.org/10.1182/blood-2018-99-116260

Published: 2018

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders

Immunological Consequences of Lenalidomide with and without Dexamethasone in Newly Diagnosed Multiple Myeloma

A Discrete Event Simulation Model to Evaluate the Impact of Treatment Sequences on Long-Term Patient Outcomes in Multiple Myeloma (MM)

Patient Experience of Chimeric Antigen Receptor (CAR)-T Cell Therapy Vs. Stem Cell Transplant: Longitudinal Patient Reported Adverse Events, Cognition and Quality of Life

RNA Splicing Defects in Cancer-Linked Genes Indicate Mutation or Focal Gene Deletion and Are Associated with TKI Resistance in CML

The SF3b Splicing Complex Regulates DNA Damage Response in Acute Lymphoblastic Leukemia

Efficacy of Fecal Microbiota Transplant in Hematological Cancers Patients with Recurrent Clostridioides Difficile Infection: A Systemic Review and Meta-Analysis

Cost-Utility Analysis of Apixaban Compared to Usual Care for the Primary Thromboprophylaxis of Ambulatory Cancer Patients Initiating Chemotherapy

Safety and Antithrombotic Efficacy of the Recombinant Protein C Activator AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis

Population Pharmacokinetic Analysis of the MDM2 Inhibitor KRT-232 (formerly AMG 232) in Subjects with Advanced Solid Tumors, Multiple Myeloma or Acute Myeloid Leukemia

Meta-Analyses of Clinical Trials Comparing the Progression Free Survival and Adverse Events in Treated Versus Observed Patients with Smoldering and Indolent Multiple Myeloma

Poisson Regression Modeling of Chronic Myeloid Leukemia Mortality Trends

Transcriptional and Functional Description of Stem Cell Heterogeneity in Native and Transplantation Hematopoiesis

Investigation of the Significance of Son Isoform mRNA Expression in Patients with Blood Cytopenias with/without Evidence of Myeloid Neoplasia

Aspartate Beta-Hydroxylase (ASPH) As a Novel Therapeutic Target in Acute Myeloid Leukemia

Whole Genome Sequencing in Routine Hematologic Samples: How to Proceed Analyses Best When Germline Controls Are Missing?

Single Cell RNA Sequencing of Blood Outgrowth Endothelial Cells from Patients with Low Von Willebrand Factor Reveal Multiple Novel Signaling Pathways

18 f-Fludeoxyglucose and 11 c-Methionine PET/CT Scans in Patients with Multiple Myeloma Following Autologous Stem-Cell Transplantation (auto-HSCT)

Whole-Genome Genomics Correlates of Response to Anti-PD1 Therapy in Relapsed/Refractory Natural Killer/T Cell Lymphoma

Cell-Free DNA Analysis Demonstrates Comprehensive Genomic Profiling and a Facile Method to Sensitively in Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only